GZTC Message Board - Msg: 1627632

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZTC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biowa who wrote (333)	6/20/1997 9:37:00 AM
From: Steve Push	of 752

<<Noticed today's press release on the PharmaGenics deal being approved makes no mention of GZTC, just lots of references to Tissue Repair and the to-be-created Molecular Oncology. Is this some sort of hint?>> No, it's not a hint. GZTC is a minority-owned subsidiary of Genzyme Corp. Genzyme General, Tissue Repair, and Molecular Oncology are all divisions of Genzyme Corp. -- collectively, they ARE Genzyme Corp. There is no reason to mention GZTC in a Genzyme Corp. press release unless we are talking about AT-III (which Genzyme Corp. will co-market) or Genzyme Corp.'s share in the earnings or losses of GZTC. Steve Push Genzyme Corp. genzyme.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next